Ausgabe 4/2018
Inhalt (4 Artikel)
Pleiotropic Anti-atherosclerotic Effects of PCSK9 Inhibitors From Molecular Biology to Clinical Translation
Angelos D. Karagiannis, Martin Liu, Peter P. Toth, Shijia Zhao, Devendra K. Agrawal, Peter Libby, Yiannis S. Chatzizisis
Cardiometabolic Effects of Anti-obesity Pharmacotherapy
Andrew R. Crawford, Naji Alamuddin, Anastassia Amaro
A Clinical Guide to Combination Lipid-Lowering Therapy
Cori Russell, Samip Sheth, Douglas Jacoby
Evolocumab: Considerations for the Management of Hyperlipidemia
Barbara S. Wiggins, Jeffrey Senfield, Helina Kassahun, Armando Lira, Ransi Somaratne